{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T16:10:03Z","timestamp":1730995803268,"version":"3.28.0"},"reference-count":13,"publisher":"Texas Heart Institute Journal","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Myocarditis is a potentially life-threatening inflammatory disease of the myocardium, often resulting from infectious and immune-mediated responses. Clinical presentation in severe cases often results in a devastating illness requiring extracorporeal membrane oxygenation support as a result of cardiogenic shock. Although endomyocardial biopsy is still considered the gold standard for diagnosis, it often reveals nonspecific lymphocytic infiltration. Because the precise cause is usually unknown, the initial treatment typically involves immunosuppression and frequent assessment of myocardial contractility. This report presents 3 rare cases of autoimmune diseases (polymyositis, immunoglobulin G4\u2013related disease, and systemic lupus erythematosus) that require extracorporeal membrane oxygenation support as a result of fulminant myocarditis, including their follow-up periods.<\/jats:p>","DOI":"10.14503\/thij-24-8431","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T05:24:24Z","timestamp":1726464264000},"source":"Crossref","is-referenced-by-count":0,"title":["Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support"],"prefix":"10.14503","volume":"51","author":[{"given":"Filip","family":"Depta","sequence":"first","affiliation":[{"name":"Department of Critical Care, East Slovak Institute for Cardiovascular Diseases, Ko\u0161ice, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Olej\u00e1rov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Critical Care, National Institute of Cardiovascular Diseases, Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u0161an","family":"Ryb\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Critical Care, East Slovak Institute for Cardiovascular Diseases, Ko\u0161ice, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavol","family":"Mur\u00edn","sequence":"additional","affiliation":[{"name":"Department of Cardiology, East Slovak Institute for Cardiovascular Diseases, Ko\u0161ice, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00e1n","family":"\u0160vajdler","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Grendel","sequence":"additional","affiliation":[{"name":"Department of Critical Care, East Slovak Institute for Cardiovascular Diseases, Ko\u0161ice, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5628","reference":[{"issue":"16","key":"b1","series-title":"N Engl J Med","first-page":"1488","article-title":"Myocarditis","volume":"387","author":"Basso\n              C","year":"2022","unstructured":"Basso\n              C\n            \n          . Myocarditis. N Engl J Med. 2022;387(16):1488-1500. doi:10.1056\/NEJMra2114478"},{"key":"b2","series-title":"Adv Exp Med Biol","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran\n              W","year":"2017","unstructured":"Bracamonte-Baran\n              W\n            , \u010cih\u00e1kov\u00e1D. Cardiac autoimmunity: myocarditis. Adv Exp Med Biol. 2017;1003:187-221. doi:10.1007\/978-3-319-57613-8_10"},{"issue":"2","key":"b3","series-title":"J Am Coll Cardiol","first-page":"283","article-title":"\u201cBorderline\u201d myocarditis: an indication for repeat endomyocardial biopsy","volume":"15","author":"Dec\n              GW","year":"1990","unstructured":"Dec\n              GW\n            , FallonJT, SouthernJF, PalaciosI. \u201cBorderline\u201d myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol. 1990;15(2):283-289. doi:10.1016\/s0735-1097(10)80050-6"},{"issue":"33","key":"b4","series-title":"Eur Heart J","first-page":"2636","article-title":"European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio\n              ALP","year":"2013","unstructured":"Caforio\n              ALP\n            , PankuweitS, ArbustiniE, et al; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648, 2648a-2648d. doi:10.1093\/eurheartj\/eht210"},{"issue":"6","key":"b5","series-title":"Circulation","first-page":"e69","article-title":"American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association","volume":"141","author":"Kociol\n              RD","year":"2020","unstructured":"Kociol\n              RD\n            , CooperLT, FangJC, et al; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141(6):e69-e92. doi:10.1161\/CIR.0000000000000745"},{"issue":"3","key":"b6","series-title":"Sci China Life Sci","first-page":"369","article-title":"A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study","volume":"62","author":"Li\n              S","year":"2019","unstructured":"Li\n              S\n            , XuS, LiC, et al.\n          A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study. Sci China Life Sci. 2019;62(3):369-380. doi:10.1007\/s11427-018-9501-9"},{"issue":"4","key":"b7","series-title":"Heart Fail Rev","first-page":"573","article-title":"Immunomodulatory treatment for lymphocytic myocarditis\u2014a systematic review and meta-analysis","volume":"23","author":"Winter\n              MP","year":"2018","unstructured":"Winter\n              MP\n            , SulzgruberP, KollerL, BartkoP, GoliaschG, NiessnerA. Immunomodulatory treatment for lymphocytic myocarditis\u2014a systematic review and meta-analysis. Heart Fail Rev. 2018;23(4):573-581. doi:10.1007\/s10741-018-9709-9"},{"issue":"3","key":"b8","series-title":"J Clin Apher","first-page":"253","article-title":"Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy","volume":"37","author":"Kruse\n              RL","year":"2022","unstructured":"Kruse\n              RL\n            , AlbaydaJ, VozniakSO, et al.\n          Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy. J Clin Apher. 2022;37(3):253-262. doi:10.1002\/jca.21968"},{"issue":"4","key":"b9","series-title":"ESC Heart Fail","first-page":"1992","article-title":"Cardiogenic shock as the initial manifestation of systemic lupus erythematosus","volume":"7","author":"Liu\n              L","year":"2020","unstructured":"Liu\n              L\n            , DongY, GaoH, et al.\n          Cardiogenic shock as the initial manifestation of systemic lupus erythematosus. ESC Heart Fail. 2020;7(4):1992-1996. doi:10.1002\/ehf2.12806"},{"issue":"2","key":"b10","series-title":"Reumatol Clin","first-page":"114","article-title":"Systemic lupus erythematosus myocarditis after COVID-19 vaccination","volume":"19","author":"Sogbe\n              M","year":"2023","unstructured":"Sogbe\n              M\n            , Blanco-Di MatteoA, Di FriscoIM, BastidasJF, SalterainN, GaviraJJ. Systemic lupus erythematosus myocarditis after COVID-19 vaccination. Reumatol Clin. 2023;19(2):114-116. doi:10.1016\/j.reuma.2022.06.003"},{"issue":"6","key":"b11","series-title":"Eur J Heart Fail","first-page":"1033","article-title":"Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies","volume":"24","author":"Baritussio\n              A","year":"2022","unstructured":"Baritussio\n              A\n            , SchiavoA, BassoC, et al.\n          Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies. Eur J Heart Fail. 2022;24(6):1033-1044. doi:10.1002\/ejhf.2496"},{"key":"b12","series-title":"Heart Lung","first-page":"174","article-title":"Heart transplantation in systemic lupus erythematosus: a case report and meta-analysis","volume":"52","author":"Chapa\n              JJ","year":"2022","unstructured":"Chapa\n              JJ\n            , IlonzeOJ, GuglinME, RaoRA. Heart transplantation in systemic lupus erythematosus: a case report and meta-analysis. Heart Lung. 2022;52:174-181. doi:10.1016\/j.hrtlng.2022.01.003"},{"issue":"4","key":"b13","series-title":"Heart","article-title":"Heart transplant for dilated cardiomyopathy associated with polymyositis","volume":"82","author":"Afzal\n              A","year":"1999","unstructured":"Afzal\n              A\n            , HigginsRS, PhilbinEF. Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart. 1999;82(4):e4. doi:10.1136\/hrt.82.4.e4"}],"container-title":["Texas Heart Institute Journal"],"original-title":[],"link":[{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/51\/2\/article-e248431.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/thij\/article-pdf\/doi\/10.14503\/THIJ-24-8431\/3430303\/i1526-6702-51-2-e248431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/51\/2\/article-e248431.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/51\/2\/article-e248431.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:38:55Z","timestamp":1730993935000},"score":1,"resource":{"primary":{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/51\/2\/article-e248431.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":13,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.14503\/thij-24-8431","relation":{},"ISSN":["1526-6702","0730-2347"],"issn-type":[{"type":"electronic","value":"1526-6702"},{"type":"print","value":"0730-2347"}],"subject":[],"published":{"date-parts":[[2024]]}}}